We are live on ! Find out more
EWA

Evolution Wealth Advisors Portfolio holdings

AUM $981M
1-Year Est. Return 21.2%
This Fund
S&P 500
This Quarter Est. Return
+8.29%
1 Year Est. Return
+21.2%
3 Year Est. Return
+66.36%
5 Year Est. Return
+44.78%
10 Year Est. Return
AUM
$492M
AUM Growth
+$44.1M
Cap. Flow
+$69.8M
Cap. Flow %
14.18%
Top 10 Hldgs %
51.4%
Holding
683
New
43
Increased
101
Reduced
154
Closed
57
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MXIM
401
DELISTED
Maxim Integrated Products
MXIM
$11K ﹤0.01%
101
ATVI
402
DELISTED
Activision Blizzard
ATVI
$11K ﹤0.01%
119
ALXO icon
403
ALX Oncology
ALXO
$272M
$10K ﹤0.01%
178
AXP icon
404
American Express
AXP
$238B
$10K ﹤0.01%
61
DVN icon
405
Devon Energy
DVN
$51.8B
$10K ﹤0.01%
330
FATE icon
406
Fate Therapeutics
FATE
$301M
$10K ﹤0.01%
120
-12
-9% -$967
IMMP
407
Immutep
IMMP
$57.3M
$10K ﹤0.01%
2,500
MCK icon
408
McKesson
MCK
$95.3B
$10K ﹤0.01%
53
MTD icon
409
Mettler-Toledo International
MTD
$26B
$10K ﹤0.01%
7
NOC icon
410
Northrop Grumman
NOC
$74.6B
$10K ﹤0.01%
28
NOW icon
411
ServiceNow
NOW
$98.4B
$10K ﹤0.01%
90
-225
-71% -$22.8K
PHAT icon
412
Phathom Pharmaceuticals
PHAT
$933M
$10K ﹤0.01%
288
QS icon
413
QuantumScape Corp
QS
$3.61B
$10K ﹤0.01%
+330
New +$10.7K
SCHW
414
Charles Schwab
SCHW
$175B
$10K ﹤0.01%
136
+10
+8% +$708
SOFI icon
415
SoFi Technologies
SOFI
$21.9B
$10K ﹤0.01%
500
WMB icon
416
Williams Companies
WMB
$91.1B
$10K ﹤0.01%
366
-356
-49% -$9.12K
ABCL icon
417
AbCellera Biologics
ABCL
$1.75B
$9K ﹤0.01%
+415
New +$11.4K
ACAD icon
418
Acadia Pharmaceuticals
ACAD
$4.27B
$9K ﹤0.01%
362
-216
-37% -$4.88K
BAH icon
419
Booz Allen Hamilton
BAH
$7.93B
$9K ﹤0.01%
103
+15
+17% +$1.27K
BCAB icon
420
BioAtla
BCAB
$5.63M
$9K ﹤0.01%
4
FDMT icon
421
4D Molecular Therapeutics
FDMT
$573M
$9K ﹤0.01%
361
+75
+26% +$2.3K
FRT icon
422
Federal Realty Investment Trust
FRT
$10.8B
$9K ﹤0.01%
75
NEM icon
423
Newmont
NEM
$102B
$9K ﹤0.01%
136
OLMA icon
424
Olema Pharmaceuticals
OLMA
$1B
$9K ﹤0.01%
+316
New +$8.99K
PPG icon
425
PPG Industries
PPG
$26.2B
$9K ﹤0.01%
54
-20
-27% -$3.43K

Similar funds

Evolution Wealth Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Evolution Wealth Advisors held 683 positions worth $492M, up 9.8% from $448M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Evolution Wealth Advisors deployed $69.8M of net new capital in Q2 2021, opening 43 new positions and adding to 101 existing holdings. Its largest new stake was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF: 1,049,515 shares worth $21.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 4.5% of assets, up from 4.5% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Invesco DB Commodity Index Tracking Fund, an estimated $8.55M trimmed.

  • Evolution Wealth Advisors's largest Q2 2021 buy was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF: 1,049,515 shares worth $21.1M.
  • Evolution Wealth Advisors added most to Rodgers Silicon Valley Acquisition Corp. Unit in Q2 2021, an estimated $58.7M increase.
  • Evolution Wealth Advisors's biggest Q2 2021 reduction was Invesco DB Commodity Index Tracking Fund, cutting an estimated $8.55M.
  • Evolution Wealth Advisors fully exited PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q2 2021, selling an estimated $1M.
  • Evolution Wealth Advisors's ten largest holdings make up 51% of its $492M portfolio in Q2 2021.
  • Evolution Wealth Advisors opened 43 new positions and closed 57 in Q2 2021.
  • Evolution Wealth Advisors's portfolio value rose 9.8% quarter-over-quarter to $492M.

Based on Evolution Wealth Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.